These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2301828)

  • 1. Comparative characterization of the leukocidic and hemolytic activity of Moraxella bovis.
    Hoien-Dalen PS; Rosenbusch RF; Roth JA
    Am J Vet Res; 1990 Feb; 51(2):191-6. PubMed ID: 2301828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Moraxella bovis and culture filtrates on 51Cr-labeled bovine neutrophils.
    Kagonyera GM; George L; Miller M
    Am J Vet Res; 1989 Jan; 50(1):18-21. PubMed ID: 2919823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of Moraxella bovis hemolysin.
    Sandhu TS; White FH
    Am J Vet Res; 1977 Jun; 38(6):883-5. PubMed ID: 879584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1984 Sep; 45(9):1848-51. PubMed ID: 6497144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves.
    Arora AK; Killinger AH; Mansfield ME
    Am J Vet Res; 1976 Jul; 37(7):803-5. PubMed ID: 937804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytopathic effects of Moraxella bovis on cultured bovine neutrophils and corneal epithelial cells.
    Kagonyera GM; George LW; Munn R
    Am J Vet Res; 1989 Jan; 50(1):10-7. PubMed ID: 2919815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental infectious bovine keratoconjunctivitis: efficacy of a vaccine prepared from nonhemolytic strains of Moraxella bovis.
    Pugh GW; McDonald TJ; Kopecky KE
    Am J Vet Res; 1982 Jun; 43(6):1081-4. PubMed ID: 7103179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Moraxella (Branhamella) ovis culture filtrates on bovine erythrocytes, peripheral mononuclear cells, and corneal epithelial cells.
    Cerny HE; Rogers DG; Gray JT; Smith DR; Hinkley S
    J Clin Microbiol; 2006 Mar; 44(3):772-6. PubMed ID: 16517853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae.
    Rosendal S; Devenish J; MacInnes JI; Lumsden JH; Watson S; Xun H
    Am J Vet Res; 1988 Jul; 49(7):1053-8. PubMed ID: 3421527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light and electron microscopic changes in corneas of healthy and immunomodulated calves infected with Moraxella bovis.
    Kagonyera GM; George LW; Munn R
    Am J Vet Res; 1988 Mar; 49(3):386-95. PubMed ID: 2833863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization of a Moraxella bovis cytolysin.
    Gray JT; Fedorka-Cray PJ; Rogers DG
    Vet Microbiol; 1995 Feb; 43(2-3):183-96. PubMed ID: 7740757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Pasteurella haemolytica with bovine neutrophils: identification and partial characterization of a cytotoxin.
    Baluyut CS; Simonson RR; Bemrick WJ; Maheswaran SK
    Am J Vet Res; 1981 Nov; 42(11):1920-6. PubMed ID: 7039430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections.
    Lane VM; George LW; Cleaver DM
    J Am Vet Med Assoc; 2006 Aug; 229(4):557-61. PubMed ID: 16910856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious bovine keratoconjunctivitis: effects of vaccination on Moraxella bovis carrier state in cattle.
    Pugh GW; McDonald TJ; Kopecky KE
    Am J Vet Res; 1980 Feb; 41(2):264-6. PubMed ID: 7369598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of complete RTX operons in Moraxella bovoculi and Moraxella ovis.
    Angelos JA; Ball LM; Hess JF
    Vet Microbiol; 2007 Nov; 125(1-2):73-9. PubMed ID: 17561358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody.
    Billson FM; Harbour C; Michalski WP; Tennent JM; Egerton JR; Hodgson JL
    Infect Immun; 2000 Jun; 68(6):3469-74. PubMed ID: 10816500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1985 May; 46(5):1011-4. PubMed ID: 2408520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic, phenotypic, and biological characteristics of Moraxella bovis.
    Schurig GG; Lightfoot DR; Troutt HF; Finkler BI
    Am J Vet Res; 1984 Jan; 45(1):35-9. PubMed ID: 6200014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
    George LW; Ardans A; Mihalyi J; Guerra MR
    Am J Vet Res; 1988 Nov; 49(11):1800-6. PubMed ID: 2854704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.